Vivani says Cortigent's merger into ClearOne still needs final approval, with closing expected afterward. The filing reports no completed transfer or new deal terms, so it does not change Vivani's outlook.
The transfer could move Cortigent under ClearOne, but it has not happened yet. The filing reports no new deal terms or completed transfer. Final approval is still needed, and the parties expect closing afterward. This update alone does not show a clear change in Vivani's business prospects.
ClearOne is set to take Cortigent as a wholly owned subsidiary, but final approval is still needed. The filing reports no completed transfer or new deal terms, so it does not change ClearOne's outlook.
Follow Vivani Medical, Inc. (VANI) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for VANI